This shows you the differences between two versions of the page.
Both sides previous revisionPrevious revisionNext revision | Previous revisionNext revisionBoth sides next revision | ||
home:diseases:cancer [05.16.2019] – [Recent research] sallieq | home:diseases:cancer [06.12.2019] – [Recent research] sallieq | ||
---|---|---|---|
Line 100: | Line 100: | ||
- | Women with hereditary | + | Women with hereditary cancer predispositions should |
Glioblastomas and malignant gliomas are the most common primary malignant brain tumors, with an annual incidence of 5.26 per 100,000 population. These tumors are typically associated with a dismal prognosis and poor quality of life. Only radiation exposure and certain genetic syndromes are well-defined risk factors for malignant glioma. | Glioblastomas and malignant gliomas are the most common primary malignant brain tumors, with an annual incidence of 5.26 per 100,000 population. These tumors are typically associated with a dismal prognosis and poor quality of life. Only radiation exposure and certain genetic syndromes are well-defined risk factors for malignant glioma. | ||
Line 385: | Line 385: | ||
In this large population-based gastro-oesophageal cancer cohort, we found moderately reduced cancer-specific mortality among ARB users. However, confirmation in further independent epidemiological studies with sufficient staging information is required. | In this large population-based gastro-oesophageal cancer cohort, we found moderately reduced cancer-specific mortality among ARB users. However, confirmation in further independent epidemiological studies with sufficient staging information is required. | ||
- | miR-205 mediates the inhibition of cervical cancer cell proliferation using olmesartan. | + | miR-205 mediates the inhibition of cervical cancer cell proliferation using olmesartan. |
Therapeutic potentials of SCFA receptors [section 7 in | Therapeutic potentials of SCFA receptors [section 7 in | ||
Recent progress in understanding the role of GPR41, GPR43 and GPR109A in health and disease demonstrate that these receptors do not just regulate inflammation and cancer in intestine, but also influence other gastrointestinal functions, allergies, adipogenesis, | Recent progress in understanding the role of GPR41, GPR43 and GPR109A in health and disease demonstrate that these receptors do not just regulate inflammation and cancer in intestine, but also influence other gastrointestinal functions, allergies, adipogenesis, | ||
+ | | ||
+ | |||
+ | | ||
+ | |||
+ | Using metabolomics, | ||